| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 28152-90-1 | Proinsulin C-Peptide(31-63)(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 41594-08-5 | C-Peptide 2(rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 41475-27-8 | C-Peptide 1(rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | | ([D8]Val7·10)-C-Peptide(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 57327-90-9 | (Tyr0)-C-Peptide(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 101135-67-5 | (Tyr0)-C-Peptide(dog) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 158535-55-8 | α-Helical CRF(12-41) |
≥98% | | 询价 |
| 8 | 99658-03-4 | α-Helical CRF(9-41) |
≥98% | | 询价 |
| 9 | | (D-Phe12,Nle21·38,α-Me-Leu37)-CRF(12-41)(human,rat) |
≥98% | | 询价 |
| 10 | 129133-27-3 | (D-Phe12,Nle21·38)-CRF(12-41)(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | | Tyr-CRF(ovine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 121249-14-7 | CRF(ovine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 100513-58-4 | Tyr-CRF(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 79985-49-2 | Dynorphin A(1-10)amide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | | (D-Ala2)-Dynorphin A(1-9) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 77259-54-2 | Dynorphin A(1-9) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 103613-84-9 | (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A(1-8) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | | (Phe7)-Dynorphin A(1-7)amide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 77101-32-7 | Dynorphin A(1-7)|Dynorphin A(1-7),porcine |
≥98% | | 询价 |
| 20 | 21866-90-0 | H-Pro-Pro-Pro-Pro-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 143547-77-7 | H-Pro-Phe-Gly-Lys-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 2812-46-6 | H-Pro-OtBu |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 2578-57-6 | H-Pro-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 2418-74-8 | H-Pro-Arg-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 3918-87-4 | H-Phe-β-Ala-OH |
≥98% | | 询价 |
| 26 | 3918-90-9 | H-Phe-Val-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 16053-39-7 | H-Phe-Ser-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 2578-81-6 | H-Phe-Phe-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 15080-84-9 | H-Phe-Met-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 22951-94-6 | H-Phe-Ile-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 38678-61-4 | H-Phe-Gly-NH2·HCl |
≥98% | | 询价 |
| 32 | 40204-87-3 | H-Phe-Gly-Gly-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 23576-42-3 | H-Phe-Gly-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 22828-05-3 | H-Phe-Asp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 150398-22-4 | H-Phe-Arg-Arg-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 42538-40-9 | H-Phe(2-Br)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 14486-13-6 | H-Met-Val-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 13589-04-3 | H-Met-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 154938-34-8 | H-Met-Trp-Tyr-Arg-Pro-Asp-Leu-Asp-Glu-Arg-Lys-Gln-Gln-Lys-Arg-Glu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 14517-43-2 | H-MET-SER-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 142702-34-9 | H-Met-Pro-OH·HCl |
≥98% | | 询价 |
| 42 | 14492-14-9 | H-Met-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 14492-15-0 | H-Met-Phe-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 13404-22-3 | H-Ala-OtBu,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 5557-83-5 | H-Ala-Obzl,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 4244-84-2 | H-b-Ala-OEt,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 68858-21-9 | HMP-Linker |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 74124-79-1 | DSC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 145013-05-4 | Bis-Boc-thiourea |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 2334434-49-8 | PF-06815345 HCl |
≥98% | | 询价 |
| 51 | 2215931-60-3 | PCSK9 degrader 1 |
≥98% | | 询价 |
| 52 | | TQB-3823 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 1401683-39-3 | Senaparib(IMP-4297)HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 1401682-78-7 | Senaparib(IMP-4297) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 2055357-65-6 | JPI-547 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 2055357-64-5 | JPI-547 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 2170491-77-5 | AMXI-5001 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 1681017-83-3 | Venadaparib(IDX-1197) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 1510829-06-7 | Vecabrutinib |
≥98% | | 询价 |
| 60 | 133152-67-7 | SI-60 |
≥98% | | 询价 |